Detalles de la búsqueda
1.
Estetrol/GPER/SERPINB2 transduction signaling inhibits the motility of triple-negative breast cancer cells.
J Transl Med
; 22(1): 450, 2024 May 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38741146
2.
Metformin counteracts stimulatory effects induced by insulin in primary breast cancer cells.
J Transl Med
; 20(1): 263, 2022 06 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35672854
3.
HMGB1 is increased in adolescents with polycystic ovary syndrome (PCOS) and decreases after treatment with myo-inositol (MYO) in combination with alpha-lipoic acid (ALA).
Gynecol Endocrinol
; 36(7): 588-593, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32054355
4.
Newly Synthesized Imino-Derivatives Analogues of Resveratrol Exert Inhibitory Effects in Breast Tumor Cells.
Int J Mol Sci
; 21(20)2020 Oct 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-33096835
5.
Current treatment for polycystic ovary syndrome: focus on adolescence.
Minerva Pediatr
; 72(4): 288-311, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32418411
6.
CFTR and FOXO1 gene expression are reduced and high mobility group box 1 (HMGB1) is increased in the ovaries and serum of women with polycystic ovarian syndrome.
Gynecol Endocrinol
; 35(10): 842-846, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-30964354
7.
Obesity, Insulin Resistance, and Colorectal Cancer: Could miRNA Dysregulation Play A Role?
Int J Mol Sci
; 20(12)2019 Jun 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-31207998
8.
Current Knowledge on Endocrine Disrupting Chemicals (EDCs) from Animal Biology to Humans, from Pregnancy to Adulthood: Highlights from a National Italian Meeting.
Int J Mol Sci
; 19(6)2018 Jun 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29865233
9.
Protective Role of GPER Agonist G-1 on Cardiotoxicity Induced by Doxorubicin.
J Cell Physiol
; 232(7): 1640-1649, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-27607345
10.
Inflammatory Diseases and Growth: Effects on the GH-IGF Axis and on Growth Plate.
Int J Mol Sci
; 18(9)2017 Aug 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-28858208
11.
From Placenta to Polycystic Ovarian Syndrome: The Role of Adipokines.
Mediators Inflamm
; 2016: 4981916, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27746590
12.
Molecular mechanisms of selective estrogen receptor modulator activity in human breast cancer cells: identification of novel nuclear cofactors of antiestrogen-ERα complexes by interaction proteomics.
J Proteome Res
; 12(1): 421-31, 2013 Jan 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-23170835
13.
GPER deletion triggers inhibitory effects in triple negative breast cancer (TNBC) cells through the JNK/c-Jun/p53/Noxa transduction pathway.
Cell Death Discov
; 9(1): 353, 2023 Sep 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-37749101
14.
The Ephrin tyrosine kinase a3 (EphA3) is a novel mediator of RAGE-prompted motility of breast cancer cells.
J Exp Clin Cancer Res
; 42(1): 164, 2023 Jul 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37434266
15.
Young Male With Shoulder Mass.
Ann Emerg Med
; 69(6): e61-e62, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28545706
16.
MicroRNA global profiling in cystic fibrosis cell lines reveals dysregulated pathways related with inflammation, cancer, growth, glucose and lipid metabolism, and fertility: an exploratory study.
Acta Biomed
; 93(3): e2022133, 2022 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35775757
17.
Triple-negative breast cancer drug resistance, durable efficacy, and cure: how advanced biological insights and emerging drug modalities could transform progress.
Expert Opin Ther Targets
; 26(6): 513-535, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35761781
18.
A Review on the Antimicrobial Activity of Schiff Bases: Data Collection and Recent Studies.
Antibiotics (Basel)
; 11(2)2022 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35203793
19.
Focal Adhesion Kinase (FAK)-Hippo/YAP transduction signaling mediates the stimulatory effects exerted by S100A8/A9-RAGE system in triple-negative breast cancer (TNBC).
J Exp Clin Cancer Res
; 41(1): 193, 2022 Jun 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35655319
20.
Specific miRNAs Change After 3 Months of GH treatment and Contribute to Explain the Growth Response After 12 Months.
Front Endocrinol (Lausanne)
; 13: 896640, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35813630